Lightnews — Scholar-powered news

LightNews

VirusSucks.com

@virussucks.com

710 followers 900 following 1.4K posts

#LongCovid #SARSCov2 Medical news #COVIDisAirborne so ventilate, filtrate, mask up!

Posts Media Videos Starter Packs

VirusSucks.com @virussucks.com · 17h

Netanyahu needs to resign so that Israelis can elect a president who is interested in peace.

VirusSucks.com @virussucks.com · 17h

Playing both sides of the fence and sloppy journalism does it.

I still read WaPo online but I notice when the facts don't always align with the truth.

VirusSucks.com @virussucks.com · 17h

JD Vance is a fraud. From his military service and name to "they're eating the dogs," he lies about everything.

He's not really a converted Catholic. He's a propagandist.

Reposted by VirusSucks.com

Ralene @gouletr.bsky.social · 19h

VirusSucks.com @virussucks.com · 17h

There were no COVID vaccines available to the public until January 2021.

Reposted by VirusSucks.com

Chise @sailorrooscout.bsky.social · 18h

SOMETHING IMPORTANT TO NOTE. This new research calls into question the idea that younger individuals and those without risk factors don’t need the vaccine. INSTEAD the data shows that, while the vaccine is MOST effective for older individuals and those with comorbidities, it was ALSO protective in

Reposted by VirusSucks.com

Chise @sailorrooscout.bsky.social · 18h

with decreased risks of severe outcomes, including among the immunocompetent and immunocompromised. The research is in line with what scientists have seen in previous years. The vaccine is efficacious, particularly against severe disease, and experts expect the new 2025–2026 COVID vaccines’

Reposted by VirusSucks.com

Chise @sailorrooscout.bsky.social · 18h

lower incidence across age groups, across major coexisting conditions, and across immunocompetence strata. Effectiveness against the composite outcome measured 37.1% at days 1 to 60, 32.5% at days 61 to 120, and 21.4% at days 121 to 180. The COVID-19 vaccine was associated with protecting veterans

Figure 3. Subgroup Analyses

Reposted by VirusSucks.com

Chise @sailorrooscout.bsky.social · 18h

10,000 persons, and risks measured 1.25 vs 3.49 per 10,000 persons. A composite of emergency department visit, hospitalization, or death yielded 28.3% effectiveness with an absolute reduction of 18.2 per 10,000 persons, with risks of 46.04 vs 64.20 per 10,000 persons. Subgroup analyses indicated

Reposted by VirusSucks.com

Chise @sailorrooscout.bsky.social · 18h

measured 44.15 in the COVID-19 vaccine group and 62.39 in the no–COVID-19 vaccine group. Hospitalization effectiveness measured 39.2%, with risks measured at 11.55 in the vaccine group versus 19.06 per 10,000 persons. Death effectiveness measured 64.0%, with an absolute reduction of 2.2 deaths per

Figure 2. Cumulative Risks of Covid-19–Associated Outcomes over 180 Days in the 2024–2025 Vaccination Season

Reposted by VirusSucks.com

Chise @sailorrooscout.bsky.social · 18h

influenza vaccination and 131,839 veterans who received influenza vaccination only between September 3 and December 31, 2024, with follow-up through June 29, 2025. At six months, vaccine effectiveness against COVID-19-associated emergency department visits measured 29.3%. Risk per 10,000 persons

Reposted by VirusSucks.com

Chise @sailorrooscout.bsky.social · 18h

Department of Veterans Affairs electronic health records to evaluate the effectiveness of the 2024–2025 COVID-19 vaccine against COVID-19–associated emergency-department visits, hospitalizations, and deaths at six months. Cohort enrollment included 164,132 veterans who received same-day COVID-19 and

Figure 1. Selection of Study Participants

Reposted by VirusSucks.com

Chise @sailorrooscout.bsky.social · 18h

study, 35% received the Pfizer vaccine (COMIRNATY), and 64% received the Moderna vaccine (Spikevax). According to the study’s authors, COVID vaccination was effective in all age groups and “in persons with or without major chronic conditions.” Researchers conducted the observational study using

Reposted by VirusSucks.com

Chise @sailorrooscout.bsky.social · 18h

A recent study published in the New England Journal of Medicine showed that last season’s 2024–2025 mRNA COVID vaccines reduced people’s risk of emergency department visits by 29%, their risk of hospitalizations by 39% and their risk of death by 64%. Of the nearly 300,000 U.S. participants in the

Reposted by VirusSucks.com

Chise @sailorrooscout.bsky.social · 18h

According to the study’s authors, COVID vaccination was effective in all ALL groups and in persons with OR without major chronic conditions.

The study has been published in the New England Journal of Medicine. YES, it is PEER-REVIEWED.
• www.nejm.org/doi/full/10....

🧪🧵⬇️

Abstract
BACKGROUND
Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, contemporary evidence on vaccine effectiveness against clinically relevant outcomes is needed.
METHODS
We conducted an observational study that used the electronic health records of the Department of Veterans Affairs to evaluate the effectiveness of the 2024-2025
Covid-19 vaccine among veterans who received the Covid-19 and influenza vaccines on the same day (164,132 participants) and in an active-comparator group of veterans who received the influenza vaccine only (131,839 participants), between September 3 and December 31, 2024. Participants were followed for 180 days or until the occurrence of an outcome, whichever came first. We used inverse-probability-weighted models to estimate vaccine effectiveness (calculated as 1 minus the risk ratio) against Covid-19-associated emergency department visits, hospitalizations, and deaths at 6 months.

RESULTS
At 6 months of follow-up, the estimated vaccine effectiveness was 29.3% (95% confidence interval [CI], 19.1 to 39.2) against Covid-19-associated emergency department visits (risk difference per 10,000 persons,
18.3; 95% CI, 10.8 to 27.6), 39.2% (95% Cl, 21.6 to 54.5) against Covid-19-associated hospitalizations (risk difference per 10,000 persons, 7.5; 95% Cl, 3.4 to 13.0), and 64.0% (95% CI, 23.0 to 85.8) against Covid-19-associated deaths (risk difference per 10,000 persons,
2.2; 95% CI, 0.5 to 6.9). Vaccine effectiveness against a composite of these outcomes was 28.3% (95% CI, 18.2 to 38.2), with a risk difference per 10,000 persons of 18.2 (95% Cl, 10.7 to 27.5). The Covid-19 vaccine was associated with decreased risks of these outcomes across prespecified subgroups defined according to age (<65 years, 65 to 75 years, and >75 years), the presence or absence of major coexisting conditions, and immunocompetence status.
CONCLUSIONS
In this national cohort of U.S. veterans, the receipt of the 2024-2025 Covid-19 vaccine was associated with decreased risks of severe clinical outcomes. (Funded by the Department of Veterans Affairs.)

Reposted by VirusSucks.com

Chise @sailorrooscout.bsky.social · 18h

Well now, would you look at that?

A massive study of NEARLY 300,000 people in the United States found that receiving an updated 2024-2025 mRNA COVID-19 vaccine REDUCED people’s risk of severe disease AND death in ALL age groups, REGARDLESS of immunity from prior infection or vaccination.

VirusSucks.com @virussucks.com · 17h

The goal is to bankrupt the farmers so that that oligarchs can buy up their farm land.

Reposted by VirusSucks.com

Jeremy Berg @jeremymberg.bsky.social · 18h

Significant reduction in ER visits, hospitalization, and death regardless of previous COVID experiences.

A graph comparing cumulative risk of ER visits, hospitalization, and death in vaccinated and unvaccinated US veterans showing a substantial benefit of vaccination.

Reposted by VirusSucks.com

Jeremy Berg @jeremymberg.bsky.social · 18h

Large study of COVID outcomes with US Veterans with updated mRNA vaccines

www.nejm.org/doi/full/10....

1/2

Association of 2024–2025 Covid-19 Vaccine with Covid-19 Outcomes in U.S. Veterans | NEJM

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

Reposted by VirusSucks.com

Marisa Kabas @marisakabas.bsky.social · 18h

"a test"? you mean...a violation?

AP: Israel plans to halve aid into Gaza over slow return of dead hostages, a test for the Gaza ceasefire

Reposted by VirusSucks.com

Imani Gandy Corn 🎃 @angryblacklady.blacksky.app · 18h

Just so everyone is clear, the main issue in the Supreme Court voting rights case tomorrow is whether it's racist against white people to enforce the Voting Rights Act.

I'm dead serious. We live in incredibly stupid times.

Reposted by VirusSucks.com

Kate @kateformeremt.bsky.social · 19h

So bragging about destroying the 1st amendment and claiming to be Christian while cheering on ICE assaulting ministers. What a flaming moron.

Reposted by VirusSucks.com

Nature @nature.com · 18h

A few hundred million years after the Big Bang, the matter between galaxies began gradually changing, from electrically neutral to ionized

go.nature.com/492EwN2

Gigantic black holes did not have starring role in early cosmic transition

Stars in young galaxies must have been responsible for stripping most intergalactic gas of its electrons.

VirusSucks.com @virussucks.com · 1d

#COVID transmission is high across Europe. Beware of travelers.

@michael-hoerger.bsky.social created this map.

#SARSCoV2

VirusSucks.com @virussucks.com · 1d

To protect yourself from #COVID and any respiratory illness, old public health mitigating measures, such as good ventilation, social distancing when appropriate, and wear an #N95 mask when you’re in a indoor space with others.

It's #airborne.